GL1X · GenesisL1 explorer

Research workbench

Structure of SARS-cov-2 main protease in complex with a covalent inhibitor

Analyse Structure of SARS-cov-2 main protease in complex with a covalent inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7RFW
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
4WI
Pockets
4 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30626% helix, 29% strandP0DTD1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.540.8516empty
21980.530.78294WI
3770.390.7816empty
4900.360.7517empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7RFW · Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.